A partnership is plausible for many reasons. However, that's not what I was discussing. Everything I heard Dave say said "Sale of Lympro". An outright sale of Lympro in the next few years is highly unlikely imo. A partnership to open up distribution channels quicker and cheaper makes a lot more sense to me. Gtd income from the flagship diagnostic on a year in year out basis while building up other assets just makes more business sense to me.